COMBINED THERAPY FOR TREATMENT OF ACUTE LEUKEMIA AND MYELODISPLASTIC SYNDROME Russian patent published in 2008 - IPC A61K31/44 A61K31/704 A61K31/7064 A61K39/44 A61P35/02

Abstract RU 2338535 C2

FIELD: medicine; oncology.

SUBSTANCE: invention can be used for treatment of an acute myelogenetic leukemia or myelodysplastic syndrome. For this purpose use a combination of preparations hemetuzumab ozohamicin, daunorubicin and cytarabinum in certain doses and regimens.

EFFECT: invention promotes effective treatment of the specified diseases due to synergistic effect at influence of these preparations on an organism.

2 cl, 2 ex

Similar patents RU2338535C2

Title	Year	Author	Number
HDM2-P53 INHIBITOR AND BCL2 INHIBITOR INTERACTION COMBINATIONS AND THEIR USE FOR CANCER TREATMENT	2019	Gerrejro, Nelson Khelajlovik, Ensar Dzhullion, Astrid Majlle, Kristof Van, Yuchzhen Fabre, Kler	RU2793123C2
CALICHEAMICIN DERIVATIVE-CARRIER CONJUGATES	2011	Kunz Artur Moran Dzhastin Kejt Rubino Dzhozef Tomas Dzhejn Neera Vidunas Judzhin Dzhozef Simpson Dzhon Maklin Robbins Pol Devid Merchant Nishit Dajdzhosef Dzhon Fransis Rappen Mark Edvard Damle Nitin Krishnadzhi Popluell Endrju Dzhordzh	RU2602878C2
CALICHEAMICIN DERIVATIVE-CARRIER CONJUGATES	2016	Kunz Artur Moran Dzhastin Kejt Rubino Dzhozef Tomas Dzhejn Neera Vidunas Yudzhin Dzhozef Simpson Dzhon Maklin Robbins Pol Devid Merchant Nishit Dajdzhosef Dzhon Fransis Rappen Mark Edvard Damle Nitin Krishnadzhi Popluell Endryu Dzhordzh	RU2678818C2
METHOD OF TREATMENT BY APPLICATION OF COMBINED THERAPY	2010	Armstrong Robert K. Belli Barbara A.	RU2543348C2
CONJUGATES "CALIHEAMICIN DERIVATIVE-CARRIER"	2003	Kunz Artur Moran Dzhastin Kejt Rubino Dzhozef Tomas Dzhejn Neera Vidunas Judzhin Dzhozef Simpson Dzhon Maklin Robbins Pol Dehvid Merchant Nishit Dajdzhosef Dzhon Fransis Rappen Mark Ehdvard Damle Nitin Krishnadzhi Popluehll Ehndrju Dzhordzh	RU2422157C2
ANALYSES AND METHODS FOR SELECTION OF TREATMENT SCHEME FOR INDIVIDUAL WITH LEUKEMIA	2016	Gordon, Max Tardi, Paul Tyner, Jeffrey Mayer, Lawrence	RU2786077C2
COMPOSITIONS AND METHODS FOR APPLYING PHORBOL ESTERS	2008	Chan Richard L. Khan' Chzhehn Tao	RU2472511C2
DOSE AND SCHEME OF INJECTION OF AN INHIBITOR OF INTERACTION OF HDM2 WITH p53 IN HEMATOLOGICAL TUMORS	2018	Ferretti, Stephane Guerreiro, Nelson Jeay, Sebastien Jullion, Astrid Meille, Christophe Wuerthner, Jens	RU2753527C2
METHOD OF ASSESSING MINIMAL RESIDUAL DISEASE (MRD) BY MULTICOLOR FLOW CYTOMETRY IN PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML) IN THE POST-INDUCTION PHASE OF TREATMENT	2022	Galtseva Irina Vladimirovna Lukianova Irina Anatolevna Davydova Iuliia Olegovna Kapranov Nikolai Mikhailovich Nikiforova Kseniia Aleksandrovna Kulikov Sergei Mikhailovich Parovichnikova Elena Nikolaevna	RU2802131C1
METHODS OF TREATING DISEASES AND DISORDERS ASSOCIATED WITH LSD1, LSD1 INHIBITORS	2020	Hitotsumachi, Hiroko Machida, Takumitsu Yamada, Masaki Keer, Harold Oganesian, Aram	RU2826217C1

RU 2 338 535 C2

Authors

Fajngol'D Dzhej Marshall

Dates

2008-11-20—Published

2002-11-06—Filed